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Sepsis still becomes a major health problem worldwide, with a fairly high mortality rate ranging
from 20 to 50%. Antibiotic therapy with rational use can reduce the mortality rate. In contrast, the
irrational use of antibiotic therapy will increase the occurrence of resistance, which impacts the
increase of morbidity, mortality, and health costs. The objective of this study was to evaluate the
quality in the use of antibiotics using the Gyssens method in patients with sepsis. This study was an
observational study with a cross-sectional method conducted at Fatmawati Central General Hospital
Jakarta from January to December 2020. The research subjects were 110 patients with sepsis who
met the inclusion criteria. In this study, 49.09% of patients used rational antibiotics and 50.91% of
patients used irrational antibiotics that were found in category VI (0.91%), V (17.28%), IVa (3.63%),
IVb (0.91%), IVc (0.91%), IIIa (3.63%), IIIb (20%), IIa (0.91%), and IIb (2.73%). The duration of
antibiotic therapy was the only factor that affected the quality of antibiotic use (p = 0.012). There was
no difference in mortality between patients with rational and irrational use of antibiotics (p = 0.333,
OR = 1.654, 95% CI 0.714-3.829). However, after adjusting for the duration of therapy, irrational
use of antibiotics significantly affected mortality (p = 0.017, OR = 3.5, 95% CI 1.255-9.761). In
conclusion, the antibiotic use in half of the sepsis patients were irrational. Since irrational use was
associated with mortality, efforts need to be taken to improve the quality of antibiotic use.
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INTRODUCTION
Sepsis still becomes a major health problem worldwide,
with a relatively high mortality rate ranging from 20
to 50% (Hotchkiss et al, 2016; WHO, 2020). Based
on data from the Ministry of Health of the Republic of
Indonesia, severe sepsis and septic shock were found
in 23 of 84 cases, with a mortality rate in care reaching
47.8% and a mortality rate in the early phase reaching
34.7% (Ministry of Health of the Republic of Indonesia,
2017).
Sepsis is defined as life-threatening organ dysfunction
caused by a dysregulated host response to infection
(Singer et al, 2016). Clinically, organ dysfunction can
be represented by an increase in the SOFA (Sequential
Organ Failure Assessment) score of 2 points or more.
Septic shock is sepsis with circulatory and cellular/
metabolic abnormalities that causes a greater risk of
mortality (Rhodes et al, 2017; Singer et al, 2016).
Sepsis is a life-threatening infection, so the 2016
Surviving Sepsis Campaign (SSC) guideline
recommends that antibiotics for sepsis patients should
be broad spectrum and be given immediately within the
first hour of a patient being diagnosed with sepsis. This

is necessary because delay in antibiotic administration
is associated with adverse outcomes. Several studies
have shown that delay in antibiotic administration is
associated with increased mortality. In addition, there
are other adverse outcomes such as increased length
of stay, acute kidney injury, acute lung injury, and the
presence of worsening organ dysfunction caused by an
exacerbated inflammatory response. The selection of
empiric antibiotic therapy for sepsis patients is broadspectrum antibiotics, because they have activity that
can inhibit the growth and kill all types of bacteria,
both gram-positive and gram-negative. Broad-spectrum
antibiotics not only provide benefits for patients with
sepsis, but can also provide some disadvantages such as
the emergence of side effects due to the use of antibiotics
and life-threatening complications due to antimicrobial
resistance (Martínez et al., 2020).
The selection of empiric antibiotics must be rational and
appropriate and based on considerations of the infected
organ underlying the sepsis. Furthermore, it is necessary
to consider other factors such as age, organ function,
degree of disease, and the causative organism such
as the map of germs/resistance map and the nature of
germs (community or nosocomial) (Gushka, 2015). In
order for antibiotics to be used rationally, it is necessary
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to evaluate the use of antibiotics (Ministry of Health
of the Republic of Indonesia, 2011b). Rational use of
antibiotics can improve patient outcomes and, at the
same time, reduce the potential for antibiotic resistance.
Otherwise, the irrational use of antibiotics can increase
the occurrence of antibiotic resistance. The high rate of
antibiotic resistance will increase morbidity, mortality,
and health costs (Andrajati, Tilaqza, & Supardi, 2017).

sepsis at Fatmawati Central General Hospital Jakarta
from January to December 2020, who met the inclusion
criteria. Inclusion criteria were adult patients aged
over 18 years with sepsis receiving antibiotic therapy.
Exclusion criteria were patients with incomplete medical
record data (which does not meet the basic information
needed in the study). Sampling was done using the total
sampling method.

Culture results has an important role in optimizing
antibiotic therapy in septic patients. Based on the 2016
SSC recommendations, appropriate microbiological
culture results should be obtained before initiating
antimicrobial therapy (Martínez et al., 2020). Previously
obtained culture results can be used to assist the doctor
in identifying the organism causing the infection and deescalation may be possible so that the goal of definitive
antibiotic therapy according to the results of the culture
can be achieved. However, if cultures are taken after
administration of antibiotics, there may be a decrease in
the blood culture yield, which can increase patient costs
and length of stay (Giuliano et al., 2019).

The independent variables in this study were the types,
the number, and the duration of antibiotic therapy. While
the dependent variable was the quality of the use of
antibiotics and the patient’s clinical outcome, namely
discharged/recovered, or died. In addition, there were
other variables/confounding variables in this study,
including the number of comorbidities and length of
stay.

A study on the qualitative evaluation of the use of
antibiotics in patients with sepsis in the Intensive Care
Unit (ICU) of the Serang Regional General Hospital
using the Gyssens method conducted by Gushka (2015)
showed that only 2 (6.9%) of antibiotic use is appropriate
(Category 0 = rational), while 27 (93.1%) of antibiotic
use is inappropriate (Category I–V = irrational). Another
study conducted at the Department of Internal Medicine
of Dr. Soetomo Regional General Hospital Surabaya
showed that 80.2% of antibiotic use is appropriate while
19.8% of antibiotic use is inappropriate in patients with
sepsis (Adiwinoto et al., 2018).
Based on previous literature searches, studies related
to the qualitative evaluation of the use of antibiotics
using the Gyssens method at Fatmawati Central General
Hospital Jakarta have been conducted on patients
with neonatal sepsis and have shown irrational use of
antibiotics (Ismaya et al., 2017). Therefore, further
research is needed in adult patients with sepsis due to
the high mortality rate for sepsis and the irrational use
of antibiotics.
METHODS
This study was an observational study using a crosssectional design with retrospective data collection
methods. This study was conducted at the Medical
Record Installation of Fatmawati Central General
Hospital Jakarta. The study population was all patients
diagnosed with sepsis at Fatmawati Central General
Hospital Jakarta from January to December 2020.
The sample in this study was patients diagnosed with
E-ISSN 2477-0612

The quality of antibiotic use in the subjects of this study
was evaluated using a Gyssens flowchart by assessing
the use of antibiotic therapy received by patients with
treatments found in the literature related to sepsis. The
primary literatures used were Guidelines for Antibiotics
Use (PPAB) and Guidelines for Clinical Practice (PPK)
of Fatmawati Central General Hospital Jakarta. If the
antibiotic administered was not listed in the literature,
then the search was continued in the Lexicomp Drug
Information Handbook or related journals. The quality
evaluation of the use of antibiotics was carried out by
the researcher together with a team of doctors and at
least 2 antimicrobial reviewers who were included in the
antimicrobial resistance control program (PPRA) team
at Fatmawati Hospital, Jakarta. This was intended to
reduce subjectivity in the evaluation process.
Based on the 2016 SSC recommendation, the antibiotics
used for septic patients are broad-spectrum antibiotics
and should be given at least one hour when the patient
is diagnosed with sepsis. However, this is quite different
from administering antibiotics in a hospital ward to
indicate a low level of compliance to the 2016 SSC
recommendations. A South Korean study found that a
lack of critical care personnel was significantly associated
with low compliance rates (Kim & Park, 2019). There are
several steps that might be taken to prevent delays in the
administration of antibiotics, including forming a multiprofessional team consisting of critical care doctors,
nurses, pharmacists, microbiologists, administrators
who work cooperatively and also developing programs
such as education and training that can aims to improve
the management of sepsis in hospitals (Martínez et al.,
2020).
In this study, the use of antibiotics was considered
rational if it met the criteria for each evaluation stage
with a Gyssens flow chart so that it was included in
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Table 1. Characteristics of patients with sepsis receiving antibiotics (n = 110)
Characteristics

Number

Percentage (%)

73
37
60.60 (± 13.88)

66.4
33.6

52
58

47.3
52.7

59
51

53.6
46.4

15
95

13.6
86.4

10
41
54
14
25
81
6
16
8

9.1
37.3
49.1
12.7
22.7
73.6
5.5
14.5
7.3

Infection sources
Lung infection
Intra-abdominal infection
Skin and soft tissue infections
Urinary tract infection
Unknown

73
11
9
2
15

66.4
10
8.2
1.8
13.6

Length of stay
1. ≤14 days
2. >14 days

94
16

85.5
14.5

Outcome
1. Discharged/ Recovered
2. Died

31
79

28.2
71.8

Age group
1. 19–65 years
2. above 65 years
Mean (SD)
Sex
1. Male
2. Female
Sepsis category
1. Sepsis
2. Septic shock
Number of comorbidities
1. 1
2. >1
Types of comorbidities
Malignancy/cancer
Metabolic disorders
Kidney diseases
Liver diseases
Cardiovascular disorders
Respiratory disorders
Indigestion
Nerve disorders
Infection/other disorders

category 0. Meanwhile, the use of antibiotics was
considered irrational if it met categories I to VI (shown
in Table 5). The patient’s clinical outcome was indicated
by mortality and recovery based on the clinician’s
assessment (the doctor in charge of the patient) listed in
the patient’s medical record.
In this study, culture examination was also carried out on
several patients with various sampling sites adjusted to
the site of infection including blood cultures, respiratory
cultures (sputum), urine cultures and skin and tissue
cultures (wound swabs). The culture results were used
as the basis for definitive antibiotic therapy according to
the type of microorganism causing the infection.
Statistical data analysis was conducted using SPSS
version 23.0, where the significance value (p-value) was
set at <0.05, indicating a significant relationship between

variables. Univariate analysis (descriptive statistics) was
used to obtain an overview of patient characteristics,
distribution of antibiotic use, quality of antibiotic use
using the Gyssens method, and patients’ clinical outcomes
by grouping and presenting the data in percentage form.
Bivariate analysis was conducted using the chi-square
test to see the effect of the independent variables on
the dependent variable and to test whether there was a
relationship between the confounding variables and the
dependent variable. Multivariate analysis was performed
using logistic regression. The analysis was considered
significant if it had a p-value <0.05.
RESULTS AND DISCUSSION
A total of 963 patients with sepsis and septic shock at
Fatmawati Central General Hospital from January to
December 2020 were divided into three categories:
E-ISSN 2477-0612
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Table 2. Distribution of antibiotic use by types of antibiotic in patients with sepsis (n = 110)
Types of Antibiotic
Empirical
Meropenem
Ceftriaxone
Cefoperazone
Levofloxacin
Ampicillin + Sulbactam
Cefotaxime
Ceftriaxone + Levofloxacin
Meropenem + Levofloxacin
Cefoperazone + Levofloxacin
Ceftriaxone + Metronidazole
Meropenem + Amikacin
Ampicillin Sulbactam + Amikacin
Meropenem + Ciprofloxacin
Meropenem + Moxifloxacin
Ceftriaxone + Ciprofloxacin
Cefoperazone + Metronidazole
Levofloxacin + Metronidazole
Cefepime + Levofloxacin
Ceftazidim + Levofloxacin
Ceftriaxone + Levofloxacin + Metronidazole
Levofloxacin + Vancomycin + Metronidazole
Meropenem + Amikacin + Azithromycin
Levofloxacin + Ampicillin Sulbactam + Amikacin
Definitive
Meropenem
Ceftriaxone + Levofloxacin
Meropenem + Levofloxacin
Meropenem + Amikacin
Total
168 patients with the primary diagnosis, 792 patients
with comorbid diagnosis, and 3 patients with the initial
diagnosis. The sampling technique in this study used
total sampling from the total number of patients with the
primary diagnosis of sepsis and septic shock as many as
168 patients. Of the 168 patients, 13 pediatric patients,
7 patients who did not receive antibiotics, 13 patients
with incomplete medical records, and 25 patients whose
medical records could not be accessed were excluded.
Therefore, the total number of patients as the research
subjects was 110 patients. The basic characteristics of
110 patients with sepsis from January to December 2020
can be seen in Table 1.
The mean age of the patients was 60.60 (±13.88) years,
with the proportion of patients in the age group 19–65
years (66.4%) having a higher percentage than the age
group over 65 years (33.6%). The proportion of male and
female is comparable, which were 52 patients (47.3%)
and 58 patients (52.7%), respectively. A total of 95
patients (86.4%) had more than one comorbidity, while
only 15 patients (13.6%) had one comorbidity. The most
common types of comorbidities are respiratory disorders
(73.6%), followed by kidney disorders (49.1%),
metabolic disorders (diabetes mellitus) (37.3%) and other
organ disorders. These results are slightly different from
studies conducted in the United States, which showed
E-ISSN 2477-0612

Number
103
14
15
8
6
5
1
19
12
8
2
1
1
1
1
1
1
1
1
1
1
1
1
1
7
2
2
2
1
110

Percentage (%)
93.66
12.72
13.64
7.28
5.45
4.54
0.91
17.28
10.91
7.28
1.81
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
6.34
1.81
1.81
1.81
0.91
100

that diabetes mellitus was the most common comorbid
disease in patients with sepsis (35%), followed by
cardiovascular disorders (32%), kidney disorders (23%),
and respiratory disorders (20%) (Novosad et al., 2016).
The most common sources of infection in this study
were pneumonia (66.4%). This result is consistent with
a study conducted in the United States, which showed
that the most common disease that cause sepsis was
pneumonia (35%) (Novosad et al., 2016). The length of
the patient’s hospitalization ranged from 2 to 24 days,
with an average of 8 days. This is similar from the
study conducted by Neira et al. (2018), which showed
that the average length of stay for sepsis patients in the
hospital was nine days and the average length of stay in
the Intensive Care Unit (ICU) was eight days. Sepsis is
the leading cause of death in hospitals, and early therapy
is considered important to achieve a better clinical
outcome. The average length of stay for sepsis patients is
also longer, requires high treatment costs, and becomes a
main economic burden for a country (Sudat, 2021).
The clinical outcome of patients diagnosed with sepsis
was mostly dead, as many as 79 patients (71.8%). This
number is higher than that of sepsis patients discharged or
recovered, with 31 patients (28.2%). This result is similar
from a study conducted at the Dharmais Cancer Hospital
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Jakarta, which showed that 68.3% of sepsis patients died
(Dewi et al., 2018). The high mortality rate in sepsis
patients can be influenced by various factors, such as the
presence of comorbidities, sources of infection, use of
respiratory support devices (ventilators), and others (Do
et al., 2021).
Most of the sources of infection in patients with sepsis
are caused by bacteria, so antibiotics are the primary
therapy in the treatment of patients with sepsis and septic
shock. Antibiotic therapy given is broad-spectrum and
appropriate to the source of infection (Rhodes et al.,
2017). An overview of the distribution of antibiotic use
by type of therapy is presented in Table 2.
The use of antibiotics was mostly for empirical
therapeutic purposes (93.66%). The combination of
ceftriaxone and levofloxacin (17.28%) was the most
commonly used antibiotic as empiric therapy, while the
most common antibiotics for definitive purposes were
meropenem alone (1.81%), a combination of ceftriaxone
and levofloxacin (1.81%), and a combination of
meropenem and levofloxacin (1.81%). The high use of
empirical antibiotics in patients with sepsis and septic
shock is because, in these conditions, it is necessary to
give antibiotics as soon as the patient is diagnosed with
sepsis or septic shock.

71

Based on the number of antibiotics therapy, antibiotics are
divided into single-antibiotic therapy and combinations
antibiotic therapy. The most widely used antibiotics
treatments for patients with sepsis and septic shock were
a combination of ceftriaxone and levofloxacin (19.09%),
meropenem alone (14.55%) and so on according to Table
3. The combination of ceftriaxone and fluoroquinolone
groups, such as levofloxacin, can be administered to
patients with sepsis or septic shock with communityacquired pneumonia (CAP) infection sources (Ministry
of Health of the Republic of Indonesia, 2017).
The most common single antibiotic was meropenem,
followed by ceftriaxone. Both are broad-spectrum
antibiotics, but the accuracy of the selection of the two
antibiotics can be adjusted according to the clinical
condition of the patient and the presence or absence of
comorbidities. A study that has been conducted at NTB
Regional General Hospital showed that ceftriaxone and
meropenem were significantly effective for the treatment
of sepsis. In the comparison of the effectiveness of the
two drugs, it was found that there was no significant
difference between ceftriaxone and meropenem in the
treatment of patients with sepsis (Eri, 2019).
Based on the duration of antibiotics therapy, most
(92.73%) antibiotics were given for less than 14 days,
and some (7.27%) were given for more than 14 days.

Table 3. Distribution of antibiotic use by number of antibiotics therapy in patients with sepsis (n = 110)
Number of Antibiotics Therapy

Number

Percentage (%)

Single therapy
Meropenem
Ceftriaxone
Cefoperazone
Levofloxacin
Ampicillin + Sulbactam
Cefotaxime
Combination therapy
Ceftriaxone + Levofloxacin
Meropenem + Levofloxacin
Cefoperazone + Levofloxacin
Ceftriaxone + Metronidazole
Meropenem + Amikacin
Ampicillin Sulbactam + Amikacin
Meropenem + Ciprofloxacin
Meropenem + Moxifloxacin
Ceftriaxone + Ciprofloxacin
Cefoperazone + Metronidazole
Levofloxacin + Metronidazole
Cefepime + Levofloxacin
Ceftazidime + Levofloxacin
Ceftriaxone + Levofloxacin + Metronidazole
Levofloxacin + Vancomycin + Metronidazole
Meropenem + Amikacin + Azithromycin
Levofloxacin + Ampicillin Sulbactam + Amikacin

51
16
15
8
6
5
1
59
21
14
8
2
2
1
1
1
1
1
1
1
1
1
1
1
1

46.37
14.55
13.64
7.28
5.45
4.54
0.91
53.63
19.09
12.72
7.28
1.81
1.81
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91

Total

110

100
E-ISSN 2477-0612
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Table 4. Distribution of antibiotic use based on the duration of therapy in patients with sepsis (n = 110)
Regimen of Antibiotic Therapy
Administration of antibiotic therapy ≤14 days
Meropenem
Ceftriaxone
Cefoperazone
Levofloxacin
Ampicillin + Sulbactam
Cefotaxime
Ceftriaxone + Levofloxacin
Meropenem + Levofloxacin
Cefoperazone + Levofloxacin
Ceftriaxone + Metronidazole
Meropenem + Amikacin
Ampicillin Sulbactam + Amikacin
Meropenem + Ciprofloxacin
Meropenem + Moxifloxacin
Ceftriaxone + Ciprofloxacin
Cefoperazone + Metronidazole
Levofloxacin + Metronidazole
Ceftazidime + Levofloxacin
Ceftriaxone+ Levofloxacin + Metronidazole
Levofloxacin + Vancomycin + Metronidazole
Meropenem + Amikacin + Azithromycin
Levofloxacin + Ampicillin Sulbactam + Amikacin
Administration of antibiotic therapy >14 days
Ceftriaxone
Meropenem
Ceftriaxone + Levofloxacin
Meropenem + Levofloxacin
Cefepime + Levofloxacin
Total
The combination of ceftriaxone and levofloxacin was
the most common regimen given for less than 14 days
(15.45%) or more than 14 days (3.63%), as shown in
Table 4.
One of the factors that support the success of antibiotic
therapy is the use of antibiotics that are adjusted to
culture results, namely as definitive therapy. In general, if
the administration of therapy has moved from empirical
to definitive therapy it may be possible to reduce the
scope of antibiotic treatment because there is no need
for antibiotics that work to target organisms other than
the cause of the patient’s infection. In addition, broadspectrum antibiotics can also cause the development
of superinfections, namely the occurrence of infections
caused by organisms that are resistant to antibiotics
that have been used and this occurs while the patient is
receiving therapy. Of the 110 patients, only 39 patients
(35.46%) were cultured. Of the 39 patients who underwent
culture testing, a total of 48 isolates were obtained. The
most isolates were sputum (41.67%), followed by blood
(37.50%), urine (14.58%), and wound swabs (6.25%).
There were 27 isolates (56.25%) with negative cultures
in the culture test results, or no microorganisms were
found. Positive cultures were mostly found in gramnegative rods as many as 15 isolates (31.25%), with
E-ISSN 2477-0612

Number
102
15
14
8
6
5
1
17
13
8
2
2
1
1
1
1
1
1
1
1
1
1
1
8
1
1
4
1
1
110

Percentage (%)
92.73
13.64
12.73
7.28
5.45
4.54
0.91
15.45
11.82
7.28
1.81
1.81
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
0.91
7.27
0.91
0.91
3.63
0.91
0.91
100

Acinetobacter baumannii (10.42%) as the most common
bacteria, followed by gram-positive coccus bacteria with
five isolates (10.2%), with Staphylococcus haemolyticus
as the most common bacteria (4.17%), and one isolate
(2.08%) found Candida tropicalis spores (data are not
shown).
The guidelines used to evaluate the quality of antibiotic
use include the Guidelines for Antibiotics Use (PPAB)
of Fatmawati Central General Hospital Jakarta in 2019,
Guidelines for Clinical Practice (PPK) of Fatmawati
Central General Hospital Jakarta, Germs Map of
Fatmawati Central General Hospital Jakarta, and related
research journals. Based on Table 6, the evaluation
results of antibiotics used in 110 patients with sepsis and
septic shock showed slight difference between rational
and irrational antibiotics. A total of 54 patients (49.09%)
used rational antibiotics and 56 patients (50.91%) used
irrational antibiotics. This result is supported by a study
conducted at the best Referral Hospital in West Java,
which showed that there were fewer rational antibiotics
(35%) than irrational antibiotics (65%) (Adani et al.,
2017). However, the results of this study are different
from the research conducted at the Department of
Internal Medicine of Dr. Soetomo Regional General
Hospital Surabaya, which showed 80.2% of antibiotic
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Table 5. The rational and irrational use of antibiotics based on the Gyssen Category
Number

Gyssens Category

1.

The completeness
of data

2.

Indication

3.

Effectiveness

4.

Tokxicity

5.

Cost

6.

Spectrum

6.

Duration

7.

Dose

8.

Interval

9.

Route

10.

Time

Rational
(category 0)
Complete data
√
Incomplete data
−
Appropriate indication
√
Inappropriate indication
−
Effective antibiotics (According to √
the culture results and germ maps)
Other antibiotics are more effective −
Antibiotics are safe/non-toxic
√
Other antibiotics are less toxic
−
Cheap antibiotics
√
Other antibiotics are cheaper
−
Narrow spectrum antibiotics
√
Other antibiotics have a narrower −
spectrum
Appropriate duration
√
Duration is too long (> 14 days)
−
Duration is too short (< 2 days)
−

Irrational
(category I–VI)
−
√ (category VI)
−
√ (category V)
−

Proper dose
Inproper dose
Proper interval
Inproper interval
Proper route
Inproper route
Proper time
Inproper time

−
√ (category IIA)
−
√ (category IIB)
−
√ (category IIC)
−
√ (category I)

use were appropriate (category 0 = rational), while
19.8% of antibiotic use were inappropriate (category
I-VI = irrational) in patients with sepsis (Adiwinoto et
al., 2018). The distribution of the use of antibiotics (241
regimens) and the Gyssens category is shown in Table 7.
Patient included in category VI was patients whose
time and duration of antibiotic administration were not
stated in the medical record, so the data was declared
incomplete and could not be continued with evaluation
to the next category. In category V, 19 patients did
not match the indication for the administration of the
antibiotics. Ceftriaxone, cefoperazone, levofloxacin,
and ampicillin-sulbactam were administered to patients
with clinical conditions who were already experiencing
septic shock and supported by high PCT values >32

ng/
mL. It would be more appropriate if patients with such
conditions were given antibiotics, such as meropenem,
since the initial diagnosis was septic shock. Thus, it
is expected to improve the patient’s clinical outcome
(PPAB of Fatmawati Central General Hospital).
Moreover, some patients received a combination therapy

√
−
√
−
√
−
√
−

√ (category IVA)
−
√ (category IVB)
−
√ (category IVC)
−
√ (category IVD)
−
√ (category IIIA)
√ (category IIIB)

of meropenem and levofloxacin. However, the patient
was still in a state of sepsis, and had kidney problems,
namely a decrease in the glomerular filtration rate (GFR)
value to 28.41 ml/minute. Thus, the therapy was not as
indicated. Meropenem (third line) can be replaced with
second-line antibiotics (ceftriaxone/cefoperazone). In
addition, meropenem therapy in sepsis patients with
kidney disease still needs to be adjusted to the dose
of the drug, while in this study, it was not carried out
(Chaijamorn et al., 2017).
There were four patients who received ineffective
antibiotics (category IVa) because they were not in
accordance with the culture results. The sensitivity
value of the antibiotic is seen in the germs map in each
treatment room of Fatmawati Central General Hospital.
There was one patient with Pseudomonas aeruginosa
isolates from sputum culture, which initially received
empiric antibiotics with a combination of ceftriaxone
and levofloxacin. However, based on the results of the
culture examination, it would be more appropriate for
E-ISSN 2477-0612
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the patient to receive ceftazidime, which had a sensitivity
of 91.7%, and ciprofloxacin which had a sensitivity of
83.3%, while the data sensitivity to ceftriaxone and
levofloxacin was not found. The next patient was a patient
with Acinetobacter baumannii isolate from sputum
culture who received a combination of cefoperazone and
levofloxacin as empiric therapy. Based on the results of
the culture examination, the recommended antibiotics
were ampicillin sulbactam with a sensitivity of 17.5%
and ciprofloxacin with a sensitivity of 11.1%, while the
data sensitivity related to cefoperazone and levofloxacin
were also not found. Another case was a patient with
isolates of Enterococcus faecium from sputum cultures
who received meropenem as empirical therapy. However,
based on the examination results of the antibiotic
culture, vancomycin with a sensitivity of 100% was
recommended, while data on meropenem sensitivity was
not found. The last patient in category IVa was a patient
with Staphylococcus haemolyticus isolate from blood
culture who received a combination of cefepime and
levofloxacin as empirical therapy. However, based on the
results of the culture examination, both were resistant,
and the recommended antibiotic was vancomycin
(germs map and the PPAB of Fatmawati Central General
Hospital). The possible reason why antibiotics are given
not according to the culture is that patients with sepsis
or septic shock are almost resistant to all antibiotics
available in the therapy, so the doctor decides to give the
antibiotic with the lowest resistance. The reason for the
absence of antibiotics can be the cause of inappropriate
use of antibiotics in patients with sepsis or septic shock.
The results of category IVb showed that there was one

patient who received a combination of meropenem and
amikacin. According to the Drug Information Handbook,
amikacin has a nephrotoxic effect than levofloxacin. This
patient also had a comorbidity, namely chronic kidney
disease with a GFR value of 7.78 ml/minute, so giving a
less toxic antibiotic, such as levofloxacin, would be more
appropriate. In category IVc, one patient received an a
branded antibiotic, whose composition was ampicillin
sulbactam. The price of branded antibiotic is more
expensive compared to generic ampicillin sulbactam
injection preparations.
In this study, there were four patients who received
antibiotic therapy with too long duration of administration
(>14 days) or included in category IIIa. The reason for the
long duration may be that the patient’s clinical condition
had not improved. However, excess use of antibiotics,
including long-term broad-spectrum antibiotic therapy,
can promote antibiotic resistance and cause side effects
in about 20% of patients, ranging from allergic reactions
to Clostridioides difficile infection (Lee et al., 2021).
The highest number of patients using irrational
antibiotics was in category IIIb (too short duration of
administration), with 22 patients. These 22 patients
received antibiotic therapy for only one day or less than
the provision for empiric antibiotics (48–72 hours).
The reason for giving antibiotics for only one day was
because the patients’ condition had worsened since
the beginning of hospital admission, and they were
diagnosed with sepsis or septic shock. Therefore, these
patients had poor clinical outcomes, namely dead.

Table 6. Evaluation of the quality of antibiotic use using the Gyssens method in patients with sepsis (n = 110)
Category Parameter

Conformity
Yes
No

Description

VI
V
IVa
IVb

Complete data
Antibiotics indicated
Effective choice of antibiotics
Less toxic alternative

109
109
90
86

1
19
4
1

One patient discontinued in category VI
19 patients discontinued in category V
Four patients discontinued in category IVa
One patient discontinued in category IVb

IVc
IVd
IIIa
IIIb
IIa
IIb
IIc

Cheaper alternative
Narrower spectrum
Long duration of administration
Short duration of administration
Proper dose
Proper interval
Proper route

85
84
84
80
58
57
54

1
0
4
22
1
3
0

One patient discontinued in category IVc

I

Proper time

54

0

0

Appropriate/ Rational

54

0
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Table 7. Distribution of antibiotics use and Gyssens category (n = 241)
Regimen of Antibiotics
Levofloxacin
Ceftriaxone
Meropenem
Cefoperazone
Ampicillin + Sulbactam
Metronidazole
Amikacin
Ciprofloxacin
Cefotaxime
Doxycycline
Ceftazidime
Vancomycin
Azithromycin
Cefepime
Moxifloxacin

0
36
25
30
10
2
6
4
1
0
1
1
1
1
0
1

I
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Gyssens Category
II
III
IV
12
14
5
6
7
5
4
8
2
1
3
2
0
4
1
0
2
0
1
1
1
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0

V
9
21
1
6
1
0
0
1
0
0
0
0
0
0
0

VI
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0

Number (%)
76 (31.53)
64 (26.55)
46 (19.08)
22 (9.12)
8 (3.31)
8 (3.31)
7 (2.90)
3 (1.24)
1 (0.41)
1 (0.41)
1 (0.41)
1 (0.41)
1 (0.41)
1 (0.41)
1 (0.41)

Category 0: rational use of antibiotics
Category I – VI: irrational use of antibiotics

Category IIa is related to the appropriate antibiotic
dose. In this study, there was one patient who received
the combination antibiotic therapy of ceftriaxone
and levofloxacin with a dose of levofloxacin that was
less than the recommended dose of 500 mg, while the
recommended dose of levofloxacin was 750 mg–1 g for
patients with no kidney disease, such as in this particular
patient. If the patient had kidney disease, it is necessary
to adjust the dose of levofloxacin for patients with a
creatinine clearance (CrCl) of 20-49 ml/minute starting
with a dose of 500 mg, then 250 mg/24 hours, and for
patients with CrCl 10-19 ml/minute starting with 500
mg, then 250 mg/48 hours (Indonesian Lung Doctors
Association, 2014).
The last category is IIb, which relates to the appropriate
interval of antibiotic use. Two patients received
meropenem with intervals of administration every 6
hours and 12 hours. Based on PPAB of Fatmawati
Central General Hospital Jakarta and Drug Information
Handbook, meropenem is given at intervals of every
8 hours. Another patient received levofloxacin with
an interval of every 48 hours even though the patient
had no history of kidney disease, meanwhile the more
appropriate interval of administration is every 24 hours.
The chi-square test results showed that the duration
of therapy (p = 0.012) was related to the quality of
antibiotic use. The test results data are presented in
Table 8. The results showed that duration of >14 days
of antibiotic therapy is more likely to cause irrational

use of antibiotics. The long duration of antibiotic therapy
affects the quality of antibiotic use because it is included
in the evaluation stage using the Gyssens method
(Gyssens, 2005).
In some patients, prolonged empiric antibiotic therapy is
sometimes necessary. This was done because of several
factors that might be the basis, such as the patient’s slow
clinical response, the presence of S. aureus bacteria
(especially
methicillin-resistant
Staphylococcus
aureus), fungal infections, viral infections, and other
immunological problems (Rhodes et al., 2017).
Meanwhile, the administration of antibiotics that are too
short (only one day) is common in patients who have
experienced a worsening of clinical conditions when
they are admitted to the hospital, so it will also affect the
assessment of the quality of antibiotic use.
This is in line with the results of the study conducted
by Kristiani et al. (2019), which showed that one of
the factors that affect the quality of antibiotic use was
the duration of antibiotic therapy. In the Antimicrobial
Stewardship Program (ASP), it is found that the duration
of antibiotic therapy has an important role in optimizing
the use of antibiotics and preventing resistance. Optimal
duration of antibiotic therapy should be recommended by
considering factors such as clinical and microbiological
efficacy and the possible risk of side effects (tolerance,
recurrence, and increased resistance) (Pezzani et al.,
2019).
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Table 8. The relationship between variables and the quality of antibiotic use (n = 110)
Variable

Characteristics

Types of
Therapy
Number of
Therapy

Rational

Irrational

OR
(95% CI)

P

Total

%

Total

%

Empiric

49

47.6

54

52.4

Definitive

5

71.4

2

28.6

Single Therapy

22

43.1

29

56.9

Combination
Therapy
≤14 days

32

54.2

27

45.8

0.332

0.640 (0.301-1.361)

54

52.9

48

47.1

0.012

Ref

>14 days

0

0

8

100

Number of
1
Comorbidities >1

8
46

53.3
48.4

7
49

46.7
51.6

0.940

Ref
1.217 (0.409-3.625)

Length of
Stay

≤14 days

47

50

47

50

Ref

>14 days

7

43.8

9

56.3

0.848

Duration of
Therapy

Ref

0.406

0.363 (0.067-1.957)
Ref

N/A

1.286 (0.442-3.738)

Table 9. The relationship of independent variabels, confounding variables, and quality of antibiotic use
with outcome in sepsis patients (n = 110)
D i s c h a r g e d / Died
Characteristics recovered
Total %
Total
Types of Therapy Empiric
29
28.2
74
Variabel

%
71.8

Definitive

2

28.6

5

71.4

Single Therapy

11

21.6

40

78.4

Combination
Therapy
≤14 days

20

33.9

39

24

23.5

>14 days

7

Number of
Comorbidities

1

Length of Stay

Number of
Therapy
Duration of
Therapy

Quality of
Antibiotic Use

OR
(95% CI)

P
1.000

Ref
0.980 (0.180-5.337)
Ref

66.1

0.222

0.536 (0.227-1.264)

78

76.5

Ref

87.5

1

12.5

0.001

3

20

12

80

>1

28

29.5

67

70.5

≤14 days

21

22.3

73

77.7

>14 days

10

62.5

6

37.5

Rational

18

33.3

36

66.7

Irrational

13

23.2

43

76.8

0.653
0.003

0.044 (0.005-0.375)
Ref
0.598 (0.157-2.284)
Ref
0.173 (0.056-0.530)

0.333

Ref
1.654 (0.714-3.829)

Table 10. Number of patients recovered or died in each Gyssen category (n = 110)
Number

Gyssens Category

Discharged / Recovered (n) Died (n)

1.
2.
3.
4.
5.
6.
7.

0
I
II
III
IV
V
VI

18
0
1
4
2
6
0
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Table 11. Factors affecting mortality in sepsis patients (n = 110)
Step
1

2

3

Variable
Quality of Antibiotic Use
Rational
Irrational
Number of Therapy
Single therapy
Combination therapy
Duration of Therapy
≤14 days
>14 days
Length of stay
≤14 days
>14 days
Quality of Antibiotic Use
Rational
Irrational
Number of Therapy
Single therapy
Combination therapy
Duration of Therapy
≤14 days
>14 days
Quality of Antibiotic Use
Rational
Irrational
Duration of Therapy
≤14 days
>14 days

CI (95%)
Lower
Upper

P

OR

0.028

Ref
3.240

1.137

9.233

0.511

Ref
0.727

0.281

1.881

0.011

Ref
0.030

0.002

0.453

0.706

Ref
0.740

0.155

3.537

0.022

Ref
3.342

1.188

9.397

0.485

Ref
0.714

0.278

1.838

0.001

Ref
0.022

0.002

0.216

0.017

Ref
3.500

1.255

9.761

0.001

Ref
0.020

0.002

0.196

Several randomized controlled trials (RCTs) have shown
that receiving longer antibiotic therapy does not improve
patient survival. It also has more severe side effects and
can increase significantly by 5% for each additional
day of antibiotic therapy. In addition to side effects,
other disadvantages are superinfection conditions and
antibiotic resistance can also increase (Spellberg & Rice,
2019). On the other hand, research evidence showed that
a shorter duration of therapy could reduce the incidence
of side effects in patients. The clinical outcome between
the two was similar between patients who received
antibiotic therapy longer or shorter than recommended
(Wilson et al., 2019).
Table 9 showed that the variable of number of therapy,
duration of therapy and length of stay have a value of
p < 0.25 so that these variables were analyzed by the
logistic regression method. While the type of therapy,

the number of comorbidities and the quality of the use
of antibiotics have p > 0.25 which indicates that these
variables have no relationship with the outcome.
Basically, the quality of antibiotic use can affect the
clinical outcome of patients with sepsis. Based on Table
9, it can be seen that both patients who used rational and
irrational antibiotics had the same bad outcome (died),
which is higher than the good outcome (discharged/
recovered) with a p-value of 0.333, which means that
there is no difference in the outcome between patients
with the rational and irrational quality of use of
antibiotics. Therefore, it can be concluded that there
is no significant relationship between the quality of
antibiotic use and outcomes of patients with sepsis and
septic shock. The explanation of the use of irrational
antibiotics and its outcome are contained in Table 10.
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The results of this study are consistent with the results of
a study that has been conducted at Dr. Sardjito Central
General Hospital Yogyakarta, which showed that there
was no significant relationship between the appropriate
use of antibiotic therapy and mortality of sepsis patients
in ICU (Sunartejo, Fitriani & Kurniawaty., 2019). The
results indicate that there may still be other factors that
cause the patient’s outcome to deteriorate (dead), so it’s
not just because of the irrational use of antibiotics.
A study that has been conducted at Dharmais Cancer
Hospital Jakarta showed that inappropriate antibiotic
doses, diagnosis of septic shock, and the presence of
two or more comorbidities could significantly increase
the mortality of patients with sepsis (Dewi et al.,
2018). Further, a study at the Vietnam Hospital also
mentioned several other factors that could affect the high
mortality rate in sepsis patients, such as the presence of
comorbidities, sources of infection, use of respiratory
support devices (ventilators), and others (Do et al.,
2021).
Multivariate analysis with logistic regression in this
study was shown in Table 11. Bivariate analysis showed
no difference between rational and irrational antibiotic to
clinical outcome. However, after controlling covariates,
irrational use of antibiotic significantly affected mortality
(p = 0.017, OR = 3.5, 95% CI 1.255-9.761), which
indicates that irrational use of antibiotic can increase the
mortality by 3.5 times. Duration of therapy may affect
the outcome of patients, therapy >14 days was shown to
be a protective factor on patient mortality (p = 0.001, OR
= 0.020, 95% CI 0.002-1.96). This is different from the
results of a systematic review and meta-analysis which
showed there was no significant difference in mortality
at a maximum follow-up of 30 days between the shorter
vs prolonged course antibiotic for sepsis (Kubo et al.,
2022).
In bivariate and multivariate analysis, the duration
of therapy >14 days was protective to mortality even
though all patients (8 patients) had irrational antibiotics
and irrational proven to cause death. These results need
further confirmation because the number of patients who
used antibiotics for >14 days was relatively small or
maybe it was other factors that caused the 8 patients to
recovered instead of the quality of antibiotics.
The limitations of this study are that data collection
was conducted retrospectively from secondary data,
including patient medical records. Therefore, the
completeness of the data was very dependent on the
recording of medical records carried out by health
workers. Data that were difficult to obtain include data
on culture results, which were only obtained completely
in a small proportion of patients with sepsis and septic
E-ISSN 2477-0612
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shock who performed culture examinations to determine
the causative pathogenic bacteria. Researchers also had
not explored further about the data of culture results
in the laboratory due to limited time. Thus, the data
of culture results could not be accessed. Data on the
side effects of antibiotics were also difficult to obtain.
These data can be obtained more fully when the study
is conducted prospectively. Moreover, not all research
samples in this study could be evaluated for the quality
of the use of antibiotics with the team of doctors and the
Antimicrobial Resistance Control Program (PPRA) team
at Fatmawati Central General Hospital Jakarta. This was
due to the limited time of some of these evaluators.
CONCLUSION
As much as 50.91% of the subjects in this study received
irrational antibiotics, with the biggest proportion was
at category IIIb (duration too short). Owing to study
result that found an association between irrational use
and mortality, this suggest that we must take efforts to
improve the quality of antibiotic use in sepsis patients.
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